Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors

被引:32
作者
Neuhaus, Brit [1 ]
Buehren, Sebastian [1 ]
Boeck, Barbara [1 ]
Alves, Frauke [2 ,3 ]
Vogel, Wolfgang F. [4 ]
Kiefer, Friedemann [1 ]
机构
[1] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, D-48149 Munster, Germany
[2] Univ Med Ctr Gottingen, Dept Hematol & Oncol, Gottingen, Germany
[3] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany
[4] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
关键词
Syk; DDR1; Migration; Epithelial cells; Cancer; DISCOIDIN DOMAIN RECEPTOR-1; PROTEIN-TYROSINE KINASE; BREAST-CANCER CELLS; EXPRESSION; COLLAGEN; GROWTH; PROGRESSION; SUPPRESSES; ACTIVATION; MOTILITY;
D O I
10.1007/s00018-011-0676-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The non-receptor tyrosine kinase Syk is a well-characterized hematopoietic signal transducer, which is also expressed in non-hematopoietic cells. In epithelial cells, the function of Syk is not wholly known. It interacts with the receptor tyrosine kinase DDR1 and is frequently lost from metastatic mammary tumors. Here, using genetic tracing, we demonstrate Syk expression in murine mammary epithelium, myoepithelium and skin epithelium, but not in intestinal or lung epithelia. Investigating possible functions of Syk, we found a substantial suppression of cell mobility that depended on Syk kinase activity in trans-well migration and wounding assays. Co-expression of DDR1 resulted in constitutive interaction and strong activation of Syk kinase. Most importantly, Syk-mediated migration inhibition was blocked in the presence of DDR1, while conversely DDR1 knockdown restored migration inhibition. Our study identifies Syk as a potent inhibitor of epithelial migration and describes a first functional consequence of the interaction with the collagen receptor DDR1.
引用
收藏
页码:3757 / 3770
页数:14
相关论文
共 46 条
  • [1] ALVES F, 1995, ONCOGENE, V10, P609
  • [2] Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: differential expression in human colon cancer cell lines
    Alves, F
    Saupe, S
    Ledwon, M
    Schaub, F
    Hiddemann, W
    Vogel, WF
    [J]. FASEB JOURNAL, 2001, 15 (07) : 1321 - 1323
  • [3] Regulation of Developmental Lymphangiogenesis by Syk+ Leukocytes
    Boehmer, Ruben
    Neuhaus, Brit
    Buehren, Sebastian
    Zhang, Dayong
    Stehling, Martin
    Boeck, Barbara
    Kiefer, Friedemann
    [J]. DEVELOPMENTAL CELL, 2010, 18 (03) : 437 - 449
  • [4] Cancer: the matrix is now in control
    Comoglio, PM
    Trusolino, L
    [J]. NATURE MEDICINE, 2005, 11 (11) : 1156 - 1159
  • [5] The Syk tyrosine kinase: A new negative regulator in tumor growth and progression
    Coopman, Peter J.
    Mueller, Susette C.
    [J]. CANCER LETTERS, 2006, 241 (02) : 159 - 173
  • [6] The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells
    Coopman, PJP
    Do, MTH
    Barth, M
    Bowden, ET
    Hayes, AJ
    Basyuk, E
    Blancato, JK
    Vezza, PR
    McLeskey, SW
    Mangeat, PH
    Mueller, SC
    [J]. NATURE, 2000, 406 (6797) : 742 - 747
  • [7] Discoidin domain receptor 1 controls growth and adhesion of mesangial cells
    Curat, CA
    Vogel, WF
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (11): : 2648 - 2656
  • [8] Dejmek J, 2005, CLIN CANCER RES, V11, P520
  • [9] DIMARCO E, 1993, J BIOL CHEM, V268, P24290
  • [10] C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer
    Evans, Elizabeth E.
    Henn, Alicia D.
    Jonason, Alan
    Paris, Mark J.
    Schiffhauer, Linda M.
    Borrello, Melinda A.
    Smith, Ernest S.
    Sahasrabudhe, Deepak M.
    Zauderer, Maurice
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (11) : 2919 - 2930